Latest Infant Formula News

The a2 Milk Company reported record FY25 results with $1.9 billion in sales and declared its first-ever dividends, while advancing a major supply chain overhaul through a key New Zealand manufacturing acquisition and divestment.

Aumake Limited reported a remarkable 213% surge in quarterly cash receipts, driven by exclusive distribution agreements and strategic cost reductions, setting the stage for profitability in FY26.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Australian Dairy Nutritionals Limited has reported a record-breaking quarter with total revenue soaring 119% year-on-year, driven by an 801% jump in nutritional powder sales and expanded distribution in China.

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Clover Corporation has upgraded its FY25 earnings forecast, expecting net profit after tax to exceed market consensus by around 20%, driven by strong sales and operational improvements.

Australian Dairy Nutritionals Limited reported a record $736k revenue from nutritional powders in Q3 FY25, driven by its new Future brand launch in China and expanding sales in Vietnam. The company’s strategic partnerships and premium product positioning signal a pivotal shift in its growth trajectory.

Nuchev Limited reported a remarkable 215% increase in quarterly revenue, driven by the strategic launch of Oli6® in Vietnam and the acquisition of bWellness, signaling robust expansion across key Asia-Pacific markets.

Aumake Limited reports a robust 160% year-on-year surge in quarterly cash receipts to A$12.7 million, driven by new strategic partnerships and operational efficiencies. The company also implements executive salary cuts to sharpen its path toward cash flow positivity.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company Limited has reported solid revenue and profit growth for the half-year ending December 2024, alongside a confident dividend declaration reflecting its strengthened financial position.